Exiqon A/S
Exiqon Announces 2014 Grant Program for microRNA, long non-coding RNA or mRNA research

DGAP-News: Exiqon A/S /

09.01.2014 / 15:51

---------------------------------------------------------------------

Exiqon A/S (NASDAQ OMX Copenhagen: 'EXQ') today announced the launch of its
2014 global research grant program, open to researchers from academic and
non-profit institutions. 

'Exiqon aims to support our customers around the world in their everyday
laboratory work and we are proud to offer excellent products for the analysis
of any RNA in any biological system. With this grant program we intend to
provide access to cutting edge technology and enable scientists to take the
next critical step in their RNA research', said Senior Vice President Sales &
Marketing, Dr. Henrik M. Pfundheller. 

The Exiqon Grant Program has been established with an internal seed funding of
3 grants each worth USD 12,500 (EUR 9,000) which will be given to researchers
who can best demonstrate how Exiqon can help them accelerate their RNA
discoveries. 

Recipients will use Exiqon Grant Program awards for the purchase of any of
Exiqon's RNA products or services. Exiqon offers a complete product line for
RNA investigation, including products for RNA isolation, microRNA microarray
analysis, qPCR analysis, Northern Blotting, In Situ Hybridization and
functional analysis studies. Exiqon also offers microRNA profiling services
based on Next Generation Sequencing, microarray and qPCR analysis, complete
with full sample QC and customized data analysis and reporting. 

Researchers are invited to submit an application outlining their research area,
project goals and proposed workflow no later than Friday, 31 January 2014.
Award conveyance through the Exiqon Grant Program does not influence, and is
not influenced by, any other existing or potential sources of project funding. 

Applications must be submitted electronically via a special Grant Program
webpage http://www.exiqon.com/ls/grants. Grant recipients will be announced
early March 2014. 

Additional information:
Additional information is available through Exiqon representatives located
across North America and Europe. Interested parties are also invited to contact
Exiqon at 1-888-647-2879 (U.S.)/ +45 4566 0888 (EU) or using
www.exiqon.com/contact.
News Source: NASDAQ OMX


End of Corporate News

---------------------------------------------------------------------

09.01.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English       
Company:     Exiqon A/S    
 
 
             Denmark       
ISIN:        DK0060077758  
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
247461 09.01.2014